19.000
+0,00%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +12.8% | -2.1% | 2 / 3 | +23.6% | -4.03 pp | -2.90 pp | +14.1% | 0.26 | 6.24 | 164 | +23,6% | 29,7 | +6,6% | 6.24 | 8.12 | −23,2% |
| Pts | 0 | 0 | 8 | 12 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 19.000 (close price on 2026-10-19)EPS (TTM): 3.046
Financial charts
1.Revenue & growth
VND bn164Q2/26
1.Revenue & growth
VND bn164Q2/26
2.Profit & growth
VND bn29,7Q2/26
3.Profit mix (Penman)
VND bn153Q2/26
4.Margins & cost structure
%36.4%Q2/26
5.Returns & cash cycle
% · days19.7%Q2/26
6.Earnings quality & cash
VND bn38,6Q2/26
7.Asset structure
VND bn1.922Q2/26
8.Funding & debt health
VND bn · times1.922Q2/26
9.Revenue backlog
VND bn117Q2/26
10.Valuation
times · %6,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %777Q2/26
Adjusted EPS growth, latest quarter
12.8%
Average adjusted EPS growth, 3 quarters
-15.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26